Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00505726 · ClinicalTrials.gov registry record
Reflectance Confocal Imaging in Cervical Cancer Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 39
- Enrollment target
NCT00505726: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00505726 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00505726 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to see if reflectance confocal microscopy works as well as standard methods to detect cancer of the cervix or precancerous lesions. Primary Objectives: 1. To identify potential clinical advantages for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using reflectance confocal microscopy. 2. To obtain real time reflected light images in vivo of sites in the human cervix. 3. To access the effects of acetic acid as a contrast agent for in vivo reflectance confocal imaging. 4. Evaluate the depth of penetration for the fiber optic confocal device and analyze the diagnostic value of images taken from different depths. 5. Determine the sensitivity and specificity of this device for the diagnosis of CIN.
Interventions
- PROCEDURE Reflectance Confocal Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2001-11 |
| Est. Completion | 2007-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00505726
The ClinicalTrials.gov registry entry for NCT00505726 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reflectance Confocal Imaging is the first listed.
NCT00505726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00505726 about?
NCT00505726 is a clinical study titled "Reflectance Confocal Imaging in Cervical Cancer Patients". The goal of this clinical research study is to see if reflectance confocal microscopy works as well as standard methods to detect cancer of the cervix or precancerous lesions. Primary Objectives: 1. To identify potential clinical advantages for a noninvasive method of diagnosing dysplasia and neop...
What is the current status of trial NCT00505726?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2001-11. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00505726?
The interventions under investigation include: Reflectance Confocal Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00505726?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.